100 Active Studies

Osteoarthritis Clinical Trials

Find actively recruiting research studies for osteoarthritis. Connect with study sites near you and explore new treatment options.

100
Active Trials
332+
Locations
124,183
Participants Needed

Recruiting Studies

RecruitingNCT06468202

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertens...

10 locations(Los Angeles, San Francisco, Chicago)
10,742 participants
Ohio State University
View Study Details
RecruitingNCT06534892

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

The purpose of this study is: * To investigate the optimal timing for revaccination after the initial RSVPreF3 OA vaccine dose, * To evaluate the long-term immune persistence and safety up to 5 conse...

10 locations(Birmingham, Birmingham, Huntsville)
10,353 participants
GlaxoSmithKline
View Study Details
RecruitingNCT05836987

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

REACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation ...

10 locations(Phoenix, Los Angeles, Los Angeles)
5,350 participants
Johns Hopkins University
View Study Details
RecruitingNCT01042379

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learn...

10 locations(Birmingham, Scottsdale, Tucson)
5,000 participants
QuantumLeap Healthcare Collaborative
View Study Details
RecruitingNCT07044297

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Researchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection. The goals of this study are to learn: * If taking MK-8527 once a month works to prevent HI...

10 locations(Birmingham, Los Angeles, San Francisco)
4,390 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06492616

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal G...

10 locations(Daphne, Chandler, Gilbert)
4,220 participants
Stemline Therapeutics, Inc.
View Study Details
RecruitingNCT06076304

Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis

Sinus infections are sometimes treated with oral antibiotics or nasal steroid sprays, while some patients get better on their own. Some patients may wait a few days or use common over-the-counter reme...

7 locations(Los Angeles, Washington D.C., Hyattsville)
3,720 participants
Daniel Merenstein
View Study Details
RecruitingNCT04045665

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet t...

10 locations(Little Rock, Los Angeles, Los Angeles)
3,200 participants
Icahn School of Medicine at Mount Sinai
View Study Details
RecruitingNCT05443737

Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients

The purpose of this study is to evaluate the effectiveness of a multi-component intervention to improve young cancer survivors' engagement in goal-concordant oncofertility care, concurrently with obse...

4 locations(Duarte, El Centro, La Jolla)
2,800 participants
University of California, San Diego
View Study Details
RecruitingNCT05586776

Decolonization to Reduce After-Surgery Events of Surgical Site Infection

The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection) is a two-arm multi-center individual placebo-controlled randomized (2,700 participants randomized 1:1)...

4 locations(Newport Beach, Orange, Sacramento)
2,700 participants
University of California, Irvine
View Study Details
RecruitingNCT03968393

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Perioperative AF After Noncardiac Surgery

Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient perioperat...

10 locations(Los Angeles, Houston, Coronel Suárez)
2,270 participants
Population Health Research Institute
View Study Details
RecruitingNCT03013998

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

This screening and multi-sub-study Phase 1b/2 trial will establish a method for genomic screening followed by assigning and accruing simultaneously to a multi-study "Master Protocol (BAML-16-001-M1)."...

10 locations(Phoenix, Los Angeles, San Francisco)
2,000 participants
Beat AML, LLC
View Study Details
RecruitingNCT05712200

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

A study to evaluate the effect of abelacimab relative to placebo on the rate of ischemic stroke or systemic embolism (SE) in patients with Atrial Fibrillation (AF) who have been deemed by their respon...

10 locations(Birmingham, Mobile, Gilbert)
1,900 participants
Anthos Therapeutics, Inc.
View Study Details
RecruitingNCT05050162

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

This phase II/III trial compares whether cisplatin given weekly with radiation therapy is better tolerated than cisplatin given every three weeks with radiation therapy for the treatment of head and n...

10 locations(Mobile, Jonesboro, Little Rock)
1,714 participants
NRG Oncology
View Study Details
RecruitingNCT06238622

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medic...

10 locations(Birmingham, Tucson, Los Angeles)
1,700 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT05047172

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracer...

10 locations(Birmingham, Mobile, Phoenix)
1,683 participants
University of Florida
View Study Details
RecruitingNCT05304065

Youth Partners in Care for Suicide Prevention

This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 13-24 who present to the Emergency Department (ED) with suicidal ideation or...

5 locations(Los Angeles, Sylmar, Durham)
1,600 participants
University of California, Los Angeles
View Study Details
RecruitingNCT06393374

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TP...

10 locations(Mobile, Chandler, La Jolla)
1,530 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT05633654

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatmen...

10 locations(Birmingham, Huntsville, Glendale)
1,514 participants
Gilead Sciences
View Study Details
RecruitingNCT04488081

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

The goal of this project is to rapidly screen promising agents, in the setting of an adaptive platform trial, for treatment of critically ill COVID-19 patients. In this phase 2 platform design, agents...

10 locations(Birmingham, Davis, Irvine)
1,500 participants
QuantumLeap Healthcare Collaborative
View Study Details
RecruitingNCT06925737

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine called ifinatamab deruxtecan (also called I-DXd or MK-...

10 locations(Duarte, Irvine, La Jolla)
1,440 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06651281

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Researchers want to learn more about tulisokibart (also known as MK-7240) in an extension study. Tulisokibart is a medicine designed to treat active, moderate to severe Crohn's disease (CD) and ulcera...

10 locations(Bristol, Ypsilanti, Liberty)
1,380 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06972056

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

This goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive me...

7 locations(Flagstaff, Phoenix, Los Angeles)
1,335 participants
Mayo Clinic
View Study Details
RecruitingNCT04474223

Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)

Fetal complete (i.e., third degree, 3°) atrioventricular block (AVB), identified in the 2nd trimester of pregnancy in an otherwise normally developing heart, is almost universally associated with mate...

10 locations(Phoenix, Los Angeles, Palo Alto)
1,300 participants
NYU Langone Health
View Study Details
RecruitingNCT06838000

Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents

The purpose of this study is to evaluate the safety and immunogenicity of PCV21 versus 20vPCV ( 20-valent pneumococcal conjugate vaccine, Prevnar 20) for catch-up vaccination in infants (7 to 11 MoA-M...

10 locations(Paramount, Doral, Hialeah)
1,252 participants
Sanofi Pasteur, a Sanofi Company
View Study Details
RecruitingNCT06136559

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

The goal of this study is to evaluate nemtabrutinib compared with investigator's choice of ibrutinib or acalabrutinib in participants with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma...

10 locations(Mobile, Prescott, Berkeley)
1,200 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT02140255

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below the limit of detecti...

10 locations(La Jolla, Los Angeles, Los Angeles)
1,120 participants
National Institute of Allergy and Infectious Diseases (NIAID)
View Study Details
RecruitingNCT06632327

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell ...

10 locations(Birmingham, Phoenix, Phoenix)
1,100 participants
Alliance for Clinical Trials in Oncology
View Study Details
RecruitingNCT06066502

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

The goal of this interventional study is to compare standard mechanical ventilation to a lung-stress oriented ventilation strategy in patients with Acute Respiratory Distress Syndrome (ARDS). Particip...

10 locations(Tucson, La Jolla, Los Angeles)
1,100 participants
Beth Israel Deaconess Medical Center
View Study Details
RecruitingNCT05638581

Trauma Resuscitation With Low-Titer Group O Whole Blood or Products

The goal of this clinical trial is to compare the effectiveness of unseparated whole blood (referred to as Low-Titer Group O Whole Blood) and the separate components of whole blood (including red cell...

10 locations(Birmingham, Los Angeles, New Orleans)
1,100 participants
University of Alabama at Birmingham
View Study Details
RecruitingNCT06061861

Kaiser Permanente Evaluating Nutritional Interventions in Food-Insecure High-Risk Adults Study

The goal of this randomized controlled trial is to compare the effect of receiving 6 months of monetary support for healthy food through a food delivery platform on change in glycosylated hemoglobin (...

2 locations(Pasadena, Pleasanton)
1,100 participants
Kaiser Permanente
View Study Details
RecruitingNCT06841354

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer (TNBC). The main goal of this study is to learn if people treated with sac...

10 locations(Chandler, Los Angeles, San Francisco)
1,000 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06407934

A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, parallel, Phase 3 study for treatment of participants aged 12 years and older diagnosed with moderate-to-severe atop...

10 locations(Scottsdale, Scottsdale, Tempe)
961 participants
Sanofi
View Study Details
RecruitingNCT05538663

Intravesical BCG vs GEMDOCE in NMIBC

The study hypothesis is that BCG naïve non-muscle invasive bladder cancer (NMIBC) patients treated with intravesical Gemcitabine + Docetaxel (GEMDOCE) will result in a non-inferior event-free survival...

10 locations(Birmingham, Fairbanks, Gilbert)
870 participants
ECOG-ACRIN Cancer Research Group
View Study Details
RecruitingNCT06077760

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

The goal of this study is to evaluate intismeran autogene plus pembrolizumab versus placebo plus pembrolizumab for the adjuvant treatment of margin negative, completely resected Stage II, IIIA, IIIB (...

10 locations(Anchorage, Tucson, Yuma)
868 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06256588

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

The goal of this study is to assess the safety and effectiveness of Dostarlimab compared to Placebo in adult participants with Head and Neck Squamous Cell Carcinoma (HNSCC)...

10 locations(Jonesboro, Los Angeles, Solvang)
864 participants
GlaxoSmithKline
View Study Details
RecruitingNCT06289673

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

The goal of this study is to provide sufficient therapy during the time a patients' B-cell Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy) risk category is being determined. The ter...

3 locations(San Diego, Tulsa, Memphis)
850 participants
St. Jude Children's Research Hospital
View Study Details
RecruitingNCT06822790

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

This is an open-label study to be conducted in adults with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (SHTG). Each participant must have completed all required visits per protocol in t...

7 locations(Miami Lakes, Jefferson City, Omaha)
840 participants
Arrowhead Pharmaceuticals
View Study Details
RecruitingNCT05642611

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

This phase III trial compares the effect of 3 study approaches in preventing chemotherapy-induced peripheral neuropathy: 1) cryocompression, 2) continuous compression, and 3) low cyclic compression. T...

10 locations(Birmingham, Martinez, Atlanta)
777 participants
SWOG Cancer Research Network
View Study Details
RecruitingNCT06824467

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and If people who take sacituzumab tirumotecan with or without bevaciz...

10 locations(Sarasota, Jackson, Omaha)
770 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06709014

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

The goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85. It will also learn about the safety of buntanetap/Posiphen. The main q...

10 locations(Chandler, Phoenix, Scottsdale)
760 participants
Annovis Bio Inc.
View Study Details
RecruitingNCT05232916

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

This is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive and HER2/neu positive subjects who are at high risk f...

10 locations(Tucson, Fullerton, La Jolla)
750 participants
Greenwich LifeSciences, Inc.
View Study Details
RecruitingNCT06990867

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question th...

10 locations(Chicago, Baltimore, Tulsa)
740 participants
Corxel Pharmaceuticals
View Study Details
RecruitingNCT03574571

A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the comb...

10 locations(Gilbert, New Haven, Newark)
738 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingNCT06216301

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

This study, known as LUNAR-2, aims to investigate the effectiveness and safety of using TTFields, delivered by the NovoTTF-200T device, concomitantly administered with pembrolizumab and platinum-based...

10 locations(Birmingham, Goodyear, Fullerton)
734 participants
NovoCure GmbH
View Study Details
RecruitingNCT07003984

A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.

The goal of this multi-center, randomized, double-blind, placebo-controlled study is to evaluate the safety and immunogenicity of CHIKV VLP Vaccine in children 2 to \<12 years of age....

9 locations(Fountain Valley, Washington D.C., Miami)
720 participants
Bavarian Nordic
View Study Details
RecruitingNCT03907046

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atr...

10 locations(Birmingham, Mobile, Chandler)
700 participants
Yale University
View Study Details
RecruitingNCT06334315

Oral Contraceptive Pill (OCP) Pharmacogenomics

The goal of this clinical trial is to evaluate how differences in specific parts of our DNA can influence how individual bodies break down the hormones contained within oral contraceptive pills, which...

2 locations(Aurora, New Haven)
700 participants
Yale University
View Study Details
RecruitingNCT06801834

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated ex...

10 locations(Hinsdale, Springfield, Springfield)
695 participants
Gilead Sciences
View Study Details
RecruitingNCT05099770

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-bio...

10 locations(Tucson, Beverly Hills, Glendora)
685 participants
Prokidney
View Study Details
RecruitingNCT06623422

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

The goal of this study is to learn if people who receive intismeran autogene and pembrolizumab after surgery are cancer-free longer than people who receive placebo and pembrolizumab. Researchers want ...

10 locations(Gilbert, Fullerton, Los Angeles)
680 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT05094336

A Study of AMG 193 in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

The primary objective of Parts 1 and 2 of this study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D) of AMG 193 alone and ...

10 locations(Duarte, Glendale, Oxnard)
649 participants
Amgen
View Study Details
RecruitingNCT07012395

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficac...

10 locations(Canoga Park, Lancaster, Colorado Springs)
645 participants
Spyre Therapeutics, Inc.
View Study Details
RecruitingNCT06486441

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer who have received prior treatment with platinum-based chemot...

10 locations(Little Rock, Duarte, La Jolla)
640 participants
Gilead Sciences
View Study Details
RecruitingNCT06943872

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

The goal of this study is to compare how well sonrotoclax plus obinutuzumab works versus venetoclax plus rituximab in treating adults with relapsed and/or refractory (R/R) chronic lymphocytic leukemia...

10 locations(Orange, Palo Alto, San Diego)
630 participants
BeiGene
View Study Details
RecruitingNCT05061550

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

The study is intended to assess the safety and efficacy of perioperative treatment with Durvalumab in combination with Oleclumab, Monalizumab, or AZD0171 and platinum doublet chemotherapy (CTX); or Vo...

10 locations(Little Rock, Los Angeles, Oakland)
630 participants
AstraZeneca
View Study Details
RecruitingNCT05164172

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine....

10 locations(Stamford, Gulf Breeze, Hialeah)
600 participants
H. Lundbeck A/S
View Study Details
RecruitingNCT05254171

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

The study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or without SBP-101 in subjects previously untreated for me...

10 locations(Hot Springs, Fullerton, New Haven)
600 participants
Panbela Therapeutics, Inc.
View Study Details
RecruitingNCT05671510

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

The goal of this Phase 3 clinical trial is study the safety and efficacy of the nextgen anti-CTLA-4 antibody, gotistobart (ONC-392/BNT316), in patients with metastatic non-small cell lung cancer who h...

10 locations(Dothan, Russellville, Cerritos)
600 participants
OncoC4, Inc.
View Study Details
RecruitingNCT04657068

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to: * Find the recommended dose of ART0380 that can ...

10 locations(Birmingham, Little Rock, Los Angeles)
597 participants
Artios Pharma Ltd
View Study Details
RecruitingNCT06890884

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Researchers are looking for ways to treat germinal center B-cell-like diffuse large B-cell lymphoma (GCB DLBCL). DLBCL is a fast-growing blood cancer that affects B-cells. GCB is a type of DLBCL that ...

10 locations(Mobile, Glendale, Walnut Creek)
594 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT05633667

Study of Novel Treatment Combinations in Patients With Lung Cancer

The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer. Substudy-01 will compare the different novel combinations versus standa...

10 locations(Tucson, Tucson, Denver)
593 participants
Gilead Sciences
View Study Details
RecruitingNCT04575935

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

This phase III trial compares minimally invasive surgery (MIS) to laparotomy in treating patients with stage IIIC-IV ovarian, primary peritoneal, or fallopian tube cancer who are receiving chemotherap...

10 locations(Miami, Weston, Boston)
580 participants
M.D. Anderson Cancer Center
View Study Details
RecruitingNCT06615050

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

The purpose of this study is to assess Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning ...

10 locations(Palo Alto, Miami, Tampa)
572 participants
Incyte Corporation
View Study Details
RecruitingNCT06926868

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physi...

10 locations(Hot Springs, Cerritos, Cerritos)
560 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT06631287

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

The overarching goal of this study is to determine if baricitinib, as compared to placebo, will improve neurocognitive function, along with measures of physical function, quality of life, post-exertio...

4 locations(San Francisco, Atlanta, Minneapolis)
550 participants
Wes Ely
View Study Details
RecruitingNCT06693648

A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

This is a multicenter, randomized, double-blind, placebo-controlled, parallel group, 6-week trial of a formulation of AMZ001 once daily versus placebo once daily....

10 locations(Thousand Oaks, Hialeah, Longwood)
540 participants
Amzell
View Study Details
RecruitingNCT06018337

A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-free survival (PFS) by blinded independent central ...

10 locations(Tucson, Fullerton, Los Angeles)
532 participants
DualityBio Inc.
View Study Details
RecruitingNCT06383273

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

The goal of this clinical trial is to learn if MELT-300 works on procedural sedation in adult participants undergoing cataract extraction with lens replacement (CELR). It will also learn about the saf...

10 locations(Chico, Grand Junction, Jacksonville)
528 participants
Melt Pharmaceuticals
View Study Details
RecruitingNCT07015190

Neoadjuvant Darovasertib in Primary Uveal Melanoma

This is a Phase 3, randomized, multi-center, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma (OptimUM-10)...

10 locations(La Jolla, Orange, Palo Alto)
520 participants
IDEAYA Biosciences
View Study Details
RecruitingNCT06847724

An Efficacy and Safety Study With Integrated Pharmacokinetics (PK) and Pharmacodynamic (PD) Assessment to Compare the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis (RMS)

The goal of this clinical trial is to learn if drug CYB704, a proposed biosimilar to Ocrevus, works to treat multiple sclerosis in the same way as the reference product Ocrevus(R). The main questions...

10 locations(Maitland, Ormond Beach, Banja Luka)
518 participants
Sandoz
View Study Details
RecruitingNCT06096259

Preventing Injured Knees From osteoArthritis: Severity Outcomes

This study is being done to find out if metformin is effective at reducing pain by delaying the onset of post-traumatic osteoarthritis (PTOA) after anterior cruciate ligament (ACL) reconstruction. Thi...

9 locations(Atlanta, Iowa City, Lexington)
512 participants
Brigham and Women's Hospital
View Study Details
RecruitingNCT05696626

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- ...

10 locations(Scottsdale, Tucson, Santa Rosa)
500 participants
Sermonix Pharmaceuticals Inc.
View Study Details
RecruitingNCT05916339

AWARE: Management of ADHD in Autism Spectrum Disorder

This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents wit...

10 locations(Irvine, Los Angeles, Portland)
500 participants
Daniel Coury
View Study Details
RecruitingNCT05591118

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients wit...

10 locations(Birmingham, Palo Alto, Sacramento)
500 participants
NYU Langone Health
View Study Details
RecruitingNCT03401398

Stress Hydrocortisone In Pediatric Septic Shock

SHIPSS is a multi-institutional, prospective, controlled, randomized, double-blinded interventional trial that will examine the potential benefits and risks of adjunctive hydrocortisone prescribed for...

10 locations(Tucson, Los Angeles, Oakland)
500 participants
Jerry Zimmerman
View Study Details
RecruitingNCT06858111

Fertilo In Vitro Research Study and Trial

The goal of this clinical trial is to evaluate the safety and efficacy of using Fertilo for In vitro maturation (IVM) in participants 18-35 years of age. The main question it aims to answer is whether...

8 locations(Encino, Clearwater, Winter Park)
500 participants
Gameto, Inc.
View Study Details
RecruitingNCT04923334

Nonpharmacologic Pain Management in FQHC Primary Care Clinics

The goal of this study is to improve pain management and reduce opioid reliance for patients with chronic back pain in Utah Federally-Qualified Health Centers (FQHCs). The study compares the effective...

2 locations(Salt Lake City, Salt Lake City)
500 participants
University of Utah
View Study Details
RecruitingNCT05766670

Intramedullary Calcium Sulfate Antibiotic Depot

The goal of this randomized clinical trial is to study the best treatment for open lower leg fractures to prevent infection. The main questions it aims to answer is if treating tibia fracture patients...

10 locations(Los Angeles, Macon, Lexington)
497 participants
Wake Forest University Health Sciences
View Study Details
RecruitingNCT05421741

Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

This prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those treated with traditional standard of care intra...

10 locations(Gainesville, Temple Terrace, Macon)
484 participants
Wake Forest University Health Sciences
View Study Details
RecruitingNCT05919264

FOG-001 in Locally Advanced or Metastatic Solid Tumors

The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer....

10 locations(Scottsdale, Palo Alto, New Haven)
480 participants
Parabilis Medicines, Inc.
View Study Details
RecruitingNCT05863351

Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

This phase III trial compares the effect of stero-ablative radiotherapy (SAbR) followed by standard of care systemic therapy, to standard of care systemic therapy alone, in patients with kidney cancer...

10 locations(Birmingham, Phoenix, Aurora)
472 participants
ECOG-ACRIN Cancer Research Group
View Study Details
RecruitingNCT07082816

Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

This study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angle glaucoma (OAG) or ocular hypertension (OHT)....

10 locations(Dothan, Phoenix, Garden Grove)
470 participants
Alcon Research
View Study Details
RecruitingNCT07076121

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

The purpose of this study is to assess the safety and efficacy of BMS-986504, a selective, MTA-cooperative PRMT5 inhibitor, in combination with Nab-paclitaxel/Gemcitabine (nab-p/gem) versus placebo in...

10 locations(Phoenix, Springdale, San Francisco)
470 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT06605105

Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

This is a long- term extension of the double-blind trials APPROACH (CYB003-002) and EMBRACE (CYB003-003). Its aim is to examine the safety and long-term efficacy of CYB003 in participants with MDD....

2 locations(Hollywood, Atlanta)
468 participants
Cybin IRL Limited
View Study Details
RecruitingNCT06917404

A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with subcutaneous injections of placebo in participan...

3 locations(Winter Park, Lincoln, Box Hill)
466 participants
Paradigm Biopharmaceuticals Ltd.
View Study Details
RecruitingNCT06201676

Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients

The goal of this randomized clinical trial is to learn if the use of a low-dose nonsteroidal anti-inflammatory drug (NSAID), ketorolac, reduces the rate of chronic opioid use in orthopaedic polytrauma...

2 locations(Boston, Nashville)
458 participants
Massachusetts General Hospital
View Study Details
RecruitingNCT06079346

A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer

The goal of this clinical study is to compare the efficacy and safety of OT-101 in combination with mFOLFIRINOX (folinic acid, 5-FU, irinotecan, oxaliplatin) to mFOLFIRINOX alone in patients with adva...

2 locations(Detroit, Houston)
455 participants
Oncotelic Inc.
View Study Details
RecruitingNCT06935357

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

In this study, researchers will learn more about the use of felzartamab in participants with immunoglobulin A nephropathy (IgAN). This study will focus on participants who have protein in their urine ...

10 locations(Little Rock, Apple Valley, Oxnard)
454 participants
Biogen
View Study Details
RecruitingNCT05703178

Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia

The main goal of this clinical trial is to test benefits of completing online pain coping skills training program in women who have been diagnosed with stage I-III breast cancer, who have completed th...

2 locations(Chicago, Durham)
452 participants
Northwestern University
View Study Details
RecruitingNCT06413498

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

The goal of this study (iMMagine-3) is to compare the study drug, anitocabtagene autoleucel to standard of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have receiv...

10 locations(Gilbert, Los Angeles, Sacramento)
450 participants
Kite, A Gilead Company
View Study Details
RecruitingNCT05711394

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other sy...

10 locations(Huntsville, Little Rock, Little Rock)
450 participants
AbbVie
View Study Details
RecruitingNCT06153420

Study of the Research Medicine CIN-103 in Adults with Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).

The goal of this clinical trial is to evaluate if the study drug, CIN-103, can help reduce the symptoms associated with irritable bowel syndrome with predominant diarrhea (IBS-D) in adult patients. Th...

10 locations(Dothan, Huntsville, Phoenix)
450 participants
CinPhloro Pharma, LLC
View Study Details
RecruitingNCT06388733

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

The goal of this Phase 3 clinical trial is to compare the efficacy of niraparib versus temozolomide (TMZ) in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma multiforme (GBM). T...

10 locations(Birmingham, Phoenix, La Jolla)
450 participants
Ivy Brain Tumor Center
View Study Details
RecruitingNCT06702449

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

The purpose of this study is to assess safety, reactogenicity, and immune response of the candidate UTI vaccine compared to placebo in adults between and including 18-64 years of age (YOA), and to per...

8 locations(Lenexa, Secaucus, Rochester)
448 participants
GlaxoSmithKline
View Study Details
RecruitingNCT05806164

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

The goal of this clinical trial is to compare treatment outcomes between an oral medication (beta agonist) versus onabotulinumtoxinA injections in women with urgency urinary incontinence (UUI). Parti...

5 locations(Birmingham, San Diego, Washington D.C.)
432 participants
Women and Infants Hospital of Rhode Island
View Study Details
RecruitingNCT05648500

A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematosus in adult patients with moderate to severe symptoms. The main questions it aims to answer a...

10 locations(Fullerton, Huntington Park, Aurora)
420 participants
Viatris Innovation GmbH
View Study Details
RecruitingNCT05672576

A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to severe symptoms. The main questions it aims to answer ar...

10 locations(Tucson, La Jolla, Northridge)
420 participants
Viatris Innovation GmbH
View Study Details
RecruitingNCT06810505

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to...

10 locations(Huntsville, Little Rock, Little Rock)
420 participants
AbbVie
View Study Details
RecruitingNCT06699212

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

The goal of this clinical trial is to learn if ASP-1929 photoimmunotherapy (PIT) in combination with pembrolizumab works to treat recurrent squamous cell cancer of the head and neck (HNSCC) with no di...

10 locations(Duarte, Miami, Tampa)
412 participants
Rakuten Medical, Inc.
View Study Details

Frequently Asked Questions

What clinical trials are available for Osteoarthritis?

There are currently 100 actively recruiting clinical trials for osteoarthritis. These studies are testing new treatments, therapies, and interventions at research sites across 332 cities.

How do I join a Osteoarthritis clinical trial?

To join a osteoarthritis clinical trial: 1) Browse the available studies above, 2) Click on a study that interests you, 3) Complete the eligibility form, and 4) A study coordinator will contact you.

Are clinical trials free for patients?

Yes, clinical trial participation is free. In most studies, the treatment, medical tests, and doctor visits related to the trial are provided at no cost. Some studies may also compensate for time and travel.

Can I leave a clinical trial if I change my mind?

Yes, participation in any clinical trial is completely voluntary. You can withdraw at any time, for any reason, without affecting your regular medical care.